Wellumio is a revolutionary imaging technology that harnesses the power of nuclear magnetic resonance for communities least able to access MRI. The company is developing a groundbreaking product that aims to change the standard of care for pre hospital stroke diagnosis.

FounderDr Shieak Tzeng, Dr Sergei ObruchkovCEODr Shieak Tzeng, Dr Sergei ObruchkovIndustryMedtechWebsitewww.wellumio.com

Privacy Preference Center